Literature DB >> 4065173

EORTC guidelines for phase I trials with single agents in adults. EORTC New Drug Development Committee.

.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 4065173     DOI： 10.1016/0277-5379(85)90282-2

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  1 in total

1.  Phase I study of escalating dose mitoxantrone in combination with alpha-2-interferon in patients with advanced solid tumors.

Authors:  G Gasparini; S Dal Fior; F Pozza; G A Panizzoni; S Favretto; D D Von Hoff
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.